FRIDAY, DECEMBER 9, 2016

Doctors Without Borders

333 7th Avenue
New York, NY - 10001-5004

Doctors Without Borders News

Only 2 percent of DR-TB patients can access new treatments.

Doctors Without Borders released a new publication of DR-TB Drugs Under the Microscope, showing that just 2 percent out of the 150,000 people with drug-resistant tuberculosis have access to the new, better treatments for the disease. Read More »

Congo sees progress against deadly measles epidemic

The Democratic Republic of Congo's (DRC) Ministry of Public Health recently reported that the measles epidemic has started to decline, but there are still serious risks for the disease’s transmission. Read More »

Outdated practices stall drug-resistant TB fight

Leaders from Doctors Without Borders (MSF) and the Stop TB Partnership recently published the second part of the report titled "Out of Step," which was previously an outdated resource that allowed drug-resistant tuberculosis (TB) to continue spreading. Read More »

MSF treats sleeping sickness in remote DRC areas

Doctors Without Borders (MSF) has sent mobile medical teams on jeeps and motorbikes throughout the remote, insecure areas of the Democratic Republic of Congo (DRC) to diagnose, screen and treat people who have sleeping sickness. Read More »

Doctors Without Borders tries to ward off measles outbreak in Congo

The measles epidemic in Congo's Katanga province must be halted in fewer than 60 days to prevent a major health crisis, according to Doctors Without Borders.  Read More »

Measles outbreak in Democratic Republic of Congo grows worse

The current measles epidemic in the Katanga province within the Democratic Republic of Congo continues to grow worse. Read More »

Doctors Without Borders applauds clinical trial for drug-resistant TB treatment

Doctors Without Borders (DWB) has responded favorably to the recent Tuberculosis Alliance (TB) announcement about the launch of its clinical trials for new investigational drugs for XDR-RB, currently the deadliest strain of drug-resistant TB.  Read More »

Aid group targets pneumococcal diseases in South Sudan refugees

Medecins San Frontieres (Doctors Without Borders) teams based in Ethiopia’s Gambella region said on Tuesday that they will expand the vaccination packages that they offer refugees from South Sudan to include Hib (Haemophilus influenza type B) and PCV (Pneumococcal conjugate vaccine) in an effort to decrease child deaths from pneumococcal diseases. Read More »

Group urges Pfizer, Glaxo to lower vaccine prices for poor nations

Médecins Sans Frontières (Doctors Without Borders) is asking pharmaceutical companies Pfizer and GlaxoSmithKline to reduce the cost of vaccines in the world's poorest countries, vaccine newsletter FierceVaccines said Tuesday. Read More »

India denies Gilead's hepatitis C drug patent

India rejected Gilead's patent request for Sofosbuvir, a new hepatitis C (HCV) drug therapy, on Wednesday, a move that will allow other manufacturers to produce generic forms of the medication. Read More »

Doctors Without Borders go door-to-door to share antimalarial drugs in Sierra Leone

Doctors Without Borders (MSF) and Sierra Leone's Ministry of Health recently administered the largest distribution of antimalarial drugs in Freetown and five neighboring districts. Read More »

Political crisis in South Sudan hinders access to antimalarial drugs

The malaria epidemic in South Sudan is getting worse due to the political unrest in the country. Read More »

Doctors Without Borders claims TB spread due to archaic treatment methods, policies

The medical humanitarian group Doctors Without Borders/Médecins Sans Frontières (MSF) said in a recent report that the tuberculosis crisis is due to outdated policies and treatment methods. Read More »

Group distributes antimalarial drugs in Liberia as Ebola strains system

Doctors Without Borders/Medecins Sans Frontieres (MSF), an international medical humanitarian organization, is distributing antimalarial medications in Liberia. Read More »